Figure 1. Group analysis on susceptibility-weighted imaging exhibiting higher susceptibility-weighted imaging values in the COVID group when compared to healthy controls. Three significant clusters were found primarily in the white matter regions of the pre-frontal cortex and in the brainstem. The clusters (a) and (b) are observed bilaterally in the cerebral white matter near the orbitofrontal gyrus, whereas (c) lies in the midbrain region.

November 21, 2022 — Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from COVID-19, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

About one in five adults will develop long-term effects from COVID-19, according to the U.S. Centers for Disease Control and Prevention. Neurological symptoms associated with long COVID include difficulty thinking or concentrating, headache, sleep problems, lightheadedness, pins-and-needles sensation, change in smell or taste, and depression or anxiety. However, studies have found that COVID-19 may be associated with changes to the heart, lungs or other organs even in asymptomatic patients.

As more people become infected and recover from COVID-19, research has begun to emerge, focusing on the lasting consequences of the disease.

For this study, researchers used susceptibility-weighted imaging to analyze the effects that COVID-19 has on the brain. Magnetic susceptibility denotes how much certain materials, such as blood, iron and calcium, will become magnetized in an applied magnetic field. This ability aids in the detection and monitoring of a host of neurologic conditions including microbleeds, vascular malformations, brain tumors and stroke.  

“Group-level studies have not previously focused on COVID-19 changes in magnetic susceptibility of the brain despite several case reports signaling such abnormalities,” said study co-author Sapna S. Mishra, a Ph.D. candidate at the Indian Institute of Technology in Delhi. “Our study highlights this new aspect of the neurological effects of COVID-19 and reports significant abnormalities in COVID survivors.”

The researchers analyzed the susceptibility-weighted imaging data of 46 COVID-recovered patients and 30 healthy controls. Imaging was done within six months of recovery. Among patients with long COVID, the most commonly reported symptoms were fatigue, trouble sleeping, lack of attention and memory issues.

“Changes in susceptibility values of brain regions may be indicative of local compositional changes,” Mishra said. “Susceptibilities may reflect the presence of abnormal quantities of paramagnetic compounds, whereas lower susceptibility could be caused by abnormalities like calcification or lack of paramagnetic molecules containing iron.”

MRI results showed that patients who recovered from COVID-19 had significantly higher susceptibility values in the frontal lobe and brain stem compared to healthy controls. The clusters obtained in the frontal lobe primarily show differences in the white matter.

“These brain regions are linked with fatigue, insomnia, anxiety, depression, headaches and cognitive problems,” Mishra said.

Portions of the left orbital-inferior frontal gyrus (a key region for language comprehension and production) and right orbital-inferior frontal gyrus (associated with various cognitive functions including attention, motor inhibition and imagery, as well as social cognitive processes) and the adjacent white matter areas made up the frontal lobe clusters.

The researchers also found a significant difference in the right ventral diencephalon region of the brain stem. This region is associated with many crucial bodily functions, including coordinating with the endocrine system to release hormones, relaying sensory and motor signals to the cerebral cortex and regulating circadian rhythms (the sleep-wake cycle).

“This study points to serious long-term complications that may be caused by the coronavirus, even months after recovery from the infection,” Mishra said. “The present findings are from the small temporal window. However, the longitudinal time points across a couple of years will elucidate if there exists any permanent change.”

The researchers are conducting a longitudinal study on the same patient cohort to determine whether these brain abnormalities persist over a longer time frame.

Co-authors are Rakibul Hafiz, Ph.D., Tapan Gandhi, Ph.D., Vidur Mahajan, M.B.B.S., Alok Prasad, M.D., and Bharat Biswal, Ph.D.

For more information: www.rsna.org

Find more RSNA22 coverage here

 

Related COVID-19 Coverage:

Long COVID Syndrome in Children and Teens

Long COVID Implications: Increased Health Care Use After Infection With SARS-Cov-2

Lasting Lung Damage Seen in Children and Teens after COVID 

PHOTO GALLERY: How COVID-19 Appears on Medical Imaging  

COVID-19 Fallout May Lead to More Cancer Deaths   

Kawasaki-like Inflammatory Disease Affects Children With COVID-19   

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets   

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4   

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents   

Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination   

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine   

Case Study Describes One of the First U.S. Cases of MIS-C   

NIH-funded Project Wants to Identify Children at Risk for MIS-C From COVID-19 

 

 

 


Related Content

News | PACS

November 28, 2022 — At this week’s Radiological Society of North America (RSNA) annual meeting (November 27 – December 1 ...

Time November 28, 2022
arrow
News | Pediatric Imaging

November 28, 2022 — Using MRI data from the largest long-term study of brain development and child health in the United ...

Time November 28, 2022
arrow
News | Artificial Intelligence

November 28, 2022 — Flywheel, a leading data management platform for biomedical research and collaboration, is creating ...

Time November 28, 2022
arrow
News | RSNA | By Christine Book

November 27, 2022 — Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session ...

Time November 27, 2022
arrow
News | RSNA

Nov. 27, 2022 — ClariPi Inc. has announced that its ClariCT.AI software will be released on Siemens Healthineers’ ...

Time November 27, 2022
arrow
News | RSNA

November 27, 2022— Royal Philips, a global leader in health technology, today announces its portfolio of smart ...

Time November 27, 2022
arrow
News | Enterprise Imaging

November 26, 2022 — FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics ...

Time November 26, 2022
arrow
News | Computed Tomography (CT)

November 26, 2022 — As international leaders in the field of Imaging gather for the 2022 Radiological Society of North ...

Time November 26, 2022
arrow
News | Contrast Media

November 26, 2022 — Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging offering a ...

Time November 26, 2022
arrow
News | Breast Imaging

November 25, 2022 — Hologic, Inc. will exhibit its extensive portfolio of breast and skeletal health products at the ...

Time November 25, 2022
arrow
Subscribe Now